Preface content

  • Pirbright Institute “delighted” to win share of £120m Government vaccine fund

  • Pirbright study to improve the production and supply of foot-and-mouth disease vaccine

  • Pirbright is looking for a new Institute Director

  • Infection route is key to testing effectiveness of swine flu vaccines

  • Promising results in search for a more efficient vaccine against Marek’s disease

Our research


Pirbright's progress...

Trim content

® The Pirbright Institute 2016 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.